Then, comparing the data obtained from the CKD patients treated and untreated with immunosuppressants, it appears that the increase in n-6/n-3 PUFAs exerted by FGF23 is indirect and could be mediated with MCP1. This evidence concerns the gene CCL2 and chronic kidney disease.